FDA Inspection
Hahnemann Laboratories, Inc., dba Alpine PharmaceuticalsHahnemann Laboratories, Inc., dba Alpine Pharmaceuticals – FDA Inspection, Jan 31, 2025
Record Details
This FDA Inspection record concerns Hahnemann Laboratories, Inc., dba Alpine Pharmaceuticals, with an inspection on January 31, 2025, issued by the San Francisco District Office, covering human drugs.
- Inspection Date
- January 31, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 8c626f24-98c6-4e94-99d5-ee3e3880bc70
Inspection Facts
- Inspection number
- 1261710
- FDA center
- Human Drugs
Other FDA inspections of Hahnemann Laboratories, Inc., dba Alpine Pharmaceuticals
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 28, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 27, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 25, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hahnemann Laboratories, Inc., dba Alpine Pharmaceuticals
- FDA Inspection 1116226 - 2020-01-28
- FDA Inspection 1013205 - 2017-04-27
- FDA Inspection 716637 - 2011-03-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.